ArticleJournal of experimental & clinical cancer research : CR2026
Correction: Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.
Baochi Ou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.